Furthermore, high mRNA expression of STAT6 was correlated to a better OS in grade III ovarian cancer patients, but not in grade I or II ovarian cancer patients, implying that STAT6 may be a favorable prognostic indictor especially for poor differentiation ovarian cancer. Here, STAT6 is linked to ovarian carcinoma.